Scarica il programma

Preliminary Programme CHASING CARCINOMA IN SITU OF THE BLADDER EXPERTS MEETING Chairman L.F. Da Pozzo Centro Congressi ‘Papa Giovanni XXIII’ Bergamo, Italy Friday 25 september 2015 8.30 Registration 8.45 Opening address First Session: Focus on histopathology Panelists: F. Witjes, G. Conti, A. Gianatti Provoker: F. Algaba, C. Patriarca - 9.00 Histological definitions: what is Cis? P. Colombo - 9.20 Is the new CIS the old dysplasia? M. Freschi - 9.40 Chasing Cytology: role in diagnosis, current pitfalls, how suspicious is suspicious? F. Algaba - 10.00 Provoked Discussion Second Session: Focus on diagnosis and treatment Panelists: P. Mariappan, T Hermann Provoker: M. Brausi - 10.15 The natural history of Cis: prognostic considerations R. Hurle - 10.30 Current standard of care for diagnosis of Cis A.Volpe - 10.45 Role of bladder mapping: should CIS be searched for in all suspected high grade diseases? F. Witjes - 11.00 Provoked discussion 11.15 Coffee Break Sistema Qualità ISO 9001 Progettazione e Erogazione ECM Symposia Organizzazione Congressi Srl – Piazza Campetto, 2/8 16123 Genova Tel +39 010 255146 (r.a.) Fax +39 010 2770565
P.I. 03849570100
e-mail: [email protected]
sito: www.symposiacongressi.com
Third Session Round Table: Which are the current endoscopic approaches for Cis? Panelists: M.P. Laguna, A. Lapini, T. Hermann Provoker: P. Gontero -‐ 11.30 PDD T. Hermann -‐ 11.45 NBI -‐ 12.00 SPIES A. Lapini -‐ 12.15 Discussion Fourth Session 12.30 Round Table: Management of real life Cis Panelists: P. Mariappan, M. Brausi Provokers: R. Colombo, G. Conti, M.P. Laguna, R. Naspro, A. Stenzl, Topics covered: - Prognostic impact of BGC: responders and non-‐responders - When should a case be labeled BCG refractory, resistant or what? - Alternative conservative treatments in BCG? - The role of Mytomicin C (MMC)? - Any reliable tools to predict BCG response? 13.30 Lunch Fifth Session Definition of ‘Radical’ treatment Panelists: U. Studer, P. Gontero, L.F. DaPozzo - 14.10 Cystectomy in CIS: how early is early? A. Stenzl - 14.30 Assessing the risk of urethral involvement - 14.50 Upper urinary tract carcinoma in situ: a pan-‐urothelial or separate disease? M. Roscigno - 15.10 What is the best urinary diversion in CIS? R. Colombo - 15.30 Discussion Sistema Qualità ISO 9001 Progettazione e Erogazione ECM Symposia Organizzazione Congressi Srl – Piazza Campetto, 2/8 16123 Genova Tel +39 010 255146 (r.a.) Fax +39 010 2770565
P.I. 03849570100
e-mail: [email protected]
sito: www.symposiacongressi.com
Sixth Session Round Table: Focus on follow-‐up Panelists: L.F. DaPozzo, R. Colombo, U. Studer - 15:50 The best follow-‐up scheme after conservative treatment P. Gontero - 16.10 The best follow-‐up scheme after radical cystectomy U. Studer - 16.30 Discussion 17.00 Conclusion Invited FACULTY F. Algaba, Spain M Brausi, Italy P Colombo, Italy R Colombo, Italy G Conti, Italy LF da Pozzo, Italy M Freschi, Italy A Gianatti, Italy P Gontero, Italy T Hermann, Germany R Hurle, Italy M.P. Laguna, The Netherlands A Lapini, Italy P Mariappan, UK R Naspro, Italy C. Patriarca, Italy M Roscigno, Italy A Stenzl, Germany U. Studer, Switzerland A Volpe, Italy F Witjes, The Netherlands Scientific Secretariat R .Naspro (Italy) F. Pellucchi (Italy) L. Rocchini (Italy) Sistema Qualità ISO 9001 Progettazione e Erogazione ECM Symposia Organizzazione Congressi Srl – Piazza Campetto, 2/8 16123 Genova Tel +39 010 255146 (r.a.) Fax +39 010 2770565
P.I. 03849570100
e-mail: [email protected]
sito: www.symposiacongressi.com

Download Report